Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Verbal Behavior »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Verapamil < Verbal Behavior < Verbal Learning  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000900 (2002) Tricia M. Zawacki [États-Unis] ; Janet Grace ; Joseph H. Friedman ; Lewis SudarskyExecutive and emotional dysfunction in Machado-Joseph disease.
001172 (2005) Joseph H. FriedmanMore on repetitive behaviors in Parkinson's disease.
001266 (2005) Mark Slee [Australie] ; Sharavanan Parasivam ; Bill Blessing ; Kate Truck ; Bruce Day ; Dominic ThyagarajanSpeech-activated myoclonus: an uncommon form of action myoclonus.
001448 (2006) David Millar [Royaume-Uni] ; Philipa Griffiths ; Adam J. Zermansky ; David J. BurnCharacterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy.
001505 (2006) Matteo Signorini [Italie] ; Chiara VolpatoAction fluency in Parkinson's disease: a follow-up study.
001987 (2007) Laura Bonanni ; Astrid Thomas ; Vincenzo Scorrano ; Marco OnofrjTask-specific lower lip dystonia due to mantra recitation.
001F90 (2008) Aileen K. Ho [Royaume-Uni] ; John L. Bradshaw ; Robert IansekFor better or worse: The effect of levodopa on speech in Parkinson's disease.
002985 (2010) Jonathan D. Rohrer [Royaume-Uni] ; Dominic Paviour [Royaume-Uni] ; Adolfo M. Bronstein [Royaume-Uni] ; Sean S. O Ullivan [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Jason D. Warren [Royaume-Uni]Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis
002F04 (2011) Sabine Skodda [Allemagne] ; Andrea Flasskamp ; Uwe SchlegelInstability of syllable repetition as a marker of disease progression in Parkinson's disease: a longitudinal study.
003703 (2012) Roberta Zangaglia ; Chiara Pasotti ; Francesca Mancini ; Domenico Servello ; Elena Sinforiani ; Claudio PacchettiDeep brain stimulation and cognition in Parkinson's disease: an eight-year follow-up study.
003892 (2012) Jennifer Weuve [États-Unis] ; Daniel Z. Press [États-Unis] ; Francine Grodstein [États-Unis] ; Robert O. Wright [États-Unis] ; Howard Hu [États-Unis] ; Marc G. Weisskopf [États-Unis]Cumulative exposure to lead and cognition in persons with Parkinson’s disease
003A51 (2013) Anna K. Holl [Royaume-Uni] ; Leonora Wilkinson ; Sarah J. Tabrizi ; Annamaria Painold ; Marjan JahanshahiSelective executive dysfunction but intact risky decision-making in early Huntington's disease.
003B97 (2013) Sandra Roeske [Allemagne] ; Ina Filla ; Stefan Heim ; Katrin Amunts ; Christoph Helmstaedter ; Ullrich Wüllner ; Michael Wagner ; Thomas Klockgether ; Martina MinneropProgressive cognitive dysfunction in spinocerebellar ataxia type 3.
003E23 (2014) Joshua E. Aman [États-Unis] ; Aviva Abosch ; Maggie Bebler ; Chia-Hao Lu ; Jürgen KonczakSubthalamic nucleus deep brain stimulation improves somatosensory function in Parkinson's disease.
004707 (1995) N J Scolding [Royaume-Uni] ; S M Smith ; S. Sturman ; G B Brookes ; A J LeesAuctioneer's jaw: a case of occupational oromandibular hemidystonia.
004771 (1994) J N Goldenberg [États-Unis] ; S B Brown ; W J WeinerCoprolalia in younger patients with Gilles de la Tourette syndrome.
004828 (1994) S B Blunt [Royaume-Uni] ; G. Fuller ; C. Kennard ; D. BrooksOrolingual dystonia with "tip of the tongue" geste.
004B00 (1996) S. Fahn [États-Unis] ; M F Brin ; A J Dwork ; W J Weiner ; C G Goetz ; A H RajputCase 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma.
004B55 (1996) R F PfeifferAmantadine-induced "vocal" myoclonus.
004B75 (1996) B L Scott [États-Unis] ; Joseph Jankovic [États-Unis] ; D T DonovanBotulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome.
004C36 (1996) S. Salloway [États-Unis] ; C F Stewart ; L. Israeli ; X. Morales ; S. Rasmussen ; A. Blitzer ; M F BrinBotulinum toxin for refractory vocal tics.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Verbal Behavior" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Verbal Behavior" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Verbal Behavior
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024